relax regarding ce and website, page-6

Is there significant upside potential? yes.
Is there significant downside potential? yes.

How US trials are being funded is an unknown. Manufacturing costs appear to be incurred up to 9-12 months prior to sales, which may mean over the next couple of quarters cash burn will increase prior to cash receipts as increased quantities of VitroGrow for 2013-14 is manufactured. Capital adequacy is a concern.

I am on the sidelines to preserve capital until some answers become clearer.